Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism
Bioorganic Chemistry · 2026-09 · 179 · 110040
DOI: 10.1016/j.bioorg.2026.110040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Dongrong Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, People's Republic of China; National Clinical Researc…. Hauptthemen laut MEDLINE: Acute Lung Injury, Carrier Proteins, Glycolysis, Sesquiterpenes. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Tianjin Municipality, Tianjin University of Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute lung injury (ALI) is a life-threatening inflammatory condition with limited therapeutic options. Metabolic reprogramming, particularly PKM2-mediated glycolysis, plays a pivotal role in inflammatory responses, yet natural activators targeting this pathway remain largely unexplored. Herein, we found that seco-tanapartholide B (SB), a sesquiterpene lactone derived from the medicinal and edible herb Artemisia argyi, suppresses inflammation and glycolysis both in vitro and in vivo, thereby alleviating lipopolysaccharide (LPS)-induced ALI. Using thermal proteome profiling (TPP), cellular thermal shift assay (CETSA), drug affinity responsive target stability (DARTS), and bio-layer interferometry (BLI), we identified PKM2 as the direct molecular target of SB. LC-MS/MS analysis further revealed that SB covalently binds to Cys424 of PKM2 through its α-methylene-γ-lactone moiety, leading to enhanced pyruvate kinase activity and promoted PKM2 tetramerization. Consequently, this modification suppressed glycolysis as well as inflammation-related pathways, including NF-κB and STAT3 signaling, and reduced HIF-1α expression. Additionally, genetic knockdown of PKM2 attenuates the anti-inflammatory and glycolysis-inhibitory effects of SB in macrophages. Collectively, these findings identify SB as a natural PKM2 activator that therapeutically targets metabolic-inflammatory crosstalk in ALI. This study extends the potential application of PKM2 activators beyond oncology to inflammatory lung diseases and provides a biochemical rationale for promoting PKM2 tetramerization as a therapeutic strategy for ALI/acute respiratory distress syndrome (ARDS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, People's Republic of China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy (…
- School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, People's Republic of China.
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, People's Republic of China.
- Tianjin Key Laboratory of Drug Targeting and Bioimaging, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, 300384, People's Republic of China. Electronic address: shaliu@tjut.edu…
- National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy (Tianjin), Tianjin's Clinical Research Center for Cancer, Department of Molecular Pharmacology, Tianjin Medical University Ca…
Förderung
- Natural Science Foundation of Tianjin Municipality
- Tianjin University of Technology
- National Natural Science Foundation of China
Zitieren
APA
Zhu, D., Zhao, L., Li, Y., Du, L., Xu, D., Wang, P., Liu, S., & Liu, L. (2026). Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism. Bioorganic Chemistry, 179, 110040. https://doi.org/10.1016/j.bioorg.2026.110040
Vancouver
Zhu D, Zhao L, Li Y, Du L, Xu D, Wang P, et al. Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism. Bioorganic Chemistry. 2026;179:110040. doi:10.1016/j.bioorg.2026.110040
BibTeX
@article{Zhu2026,
author = {Zhu, Dongrong and Zhao, Lirong and Li, Yue and Du, Linnan and Xu, Dingqiao and Wang, Peng and Liu, Sha and Liu, Liren},
title = {Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {179},
pages = {110040},
doi = {10.1016/j.bioorg.2026.110040}
}
EUVIMED